An Open Label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Combination of Telmisartan 40mg + Amlodipine 5mg or the Combination of Telmisartan 80mg + Amlodipine 5mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.
An Open Label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Combination of Telmisartan 40mg + Amlodipine 5mg or the Combination of Telmisartan 80mg + Amlodipine 5mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.
The primary objective of this trial is to assess the efficacy and safety of the fixed dose combinations telmisartan 40 mg / amlodipine 5 mg (T40/A5) or telmisartan 80 mg / amlodipine 5 mg (T80/A5) during long-term open-label treatment.
Inclusion Criteria:
Exclusion Criteria:
Bay Roberts, Newfoundland and Labrador, Canada
Mount Pearl, Newfoundland and Labrador, Canada
Vaerløse, Denmark
Aigrefeuille S/Maine, France
Bourg Des Cptes, France
Grandchamps, France
La Chapelle /s Erdre, France
Louvigné Le Bais, France
Saint Aubin Les Châteaux, France
Gangwon-Do, South Korea